Postoperative Empyema Improves Survival in Lung Cancer
- 16 November 1972
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 287 (20), 1013-1017
- https://doi.org/10.1056/nejm197211162872004
Abstract
A retrospective chart study revealed improved survival rates in patients in whom empyema developed after surgical resection for carcinoma of the lung. The overall five-year survival rate for the empyema group of 18 patients was 50 per cent, compared to an 18 per cent five-year survival rate in a control group consisting of a random 34-patient sample of resected cases at this institution. On further analysis, the beneficial effect of intrapleural infection was found principally in patients with tumor limited to the lung and its draining regional lymph nodes. Six of seven patients in this group survived for five years.Keywords
This publication has 22 references indexed in Scilit:
- THE MEDIATOR OF CELLULAR IMMUNITYThe Journal of Experimental Medicine, 1971
- Immunotherapy for the Patient with CancerAnnals of Surgery, 1971
- Postpneumonectomy Empyema in Pulmonary Carcinoma PatientsScandinavian Journal of Thoracic and Cardiovascular Surgery, 1970
- “Lymphokines”: Non-Antibody Mediators of Cellular Immunity generated by Lymphocyte ActivationNature, 1969
- THE INFLUENCE OF IMMUNOLOGICALLY COMMITTED LYMPHOID CELLS ON MACROPHAGE ACTIVITY IN VIVOThe Journal of Experimental Medicine, 1969
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Lymphocyte in vitro Cytotoxicity: Specific Release of Lymphotoxin-like Materials from Tuberculin-sensitive Lymphoid CellsNature, 1969
- FOURTH REPORT OF THE HUMAN KIDNEY TRANSPLANT REGISTRYTransplantation, 1965
- Empyema thoracisBritish Journal of Surgery, 1965
- INFECTION AND MALIGNANT TUMOURSActa Pathologica Microbiologica Scandinavica, 1959